![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | G01N 33/574 | |
G01N 33/15 | |||
C12Q 1/68 | |||
A61P 35/00 |
(11) | Number of the document | 2524232 |
(13) | Kind of document | T |
(96) | European patent application number | 11733335.1 |
Date of filing the European patent application | 2011-01-12 | |
(97) | Date of publication of the European application | 2012-11-21 |
(45) | Date of publication and mention of the grant of the patent | 2014-08-06 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/021026 |
Date | 2011-01-12 |
(87) | Number | WO 2011/088149 |
Date | 2011-07-21 |
(30) | Number | Date | Country code |
351838 P | 2010-06-04 | US | |
328602 P | 2010-04-27 | US | |
325624 P | 2010-04-19 | US | |
294433 P | 2010-01-12 | US |
(72) |
LIU, Xinjun, US
KIM, Phillip, US
KIRKLAND, Richard, US
LEE, Tani, US
YBARRONDO, Belen, US
SINGH, Sharat, US
|
(73) |
Nestec S.A.,
Avenue Nestlé 55, 1800 Vevey,
CH
|
(54) | METHODS FOR PREDICTING RESPONSE OF TRIPLE-NEGATIVE BREAST CANCER TO THERAPY |
METHODS FOR PREDICTING RESPONSE OF TRIPLE-NEGATIVE BREAST CANCER TO THERAPY |